The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Nanotechnological carriers for cancer chemotherapy: The state of the art
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904
Quantum dots versus organic dyes as fluorescent labels
Resch-Genger, U., Grabolle, M., Cavaliere-Jaricot, S., Nitschke, R., & Nann, T. (2008) · Nature Methods · doi:10.1038/nmeth.1248 · Cited by 3,833
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Structure and design of polymeric surfactant-based drug delivery systems
Torchilin, V. P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00299-1 · Cited by 1,822
The status of platinum anticancer drugs in the clinic and in clinical trials
Wheate, N. J., Walker, S., Craig, G. E., & Oun, R. (2010) · Dalton Transactions · doi:10.1039/c0dt00292e · Cited by 1,634
Nano-graphene in biomedicine: theranostic applications
Yang, K., Feng, L., Shi, X., & Liu, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35342c · Cited by 1,634
Albumin-based nanoparticles as potential controlled release drug delivery systems
Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.031 · Cited by 1,520
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Dendrimers and dendritic polymers in drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03276-3 · Cited by 1,367
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Pinto Reis, C., Neufeld, R. J., Ribeiro, & Veiga, F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.12.003 · Cited by 1,354
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
Cisplatin Nephrotoxicity: A Review
Yao, X., Panichpisal, K., Kurtzman, N., & Nugent, K. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31812dfe1e · Cited by 1,251
Pouton, C. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00167-6 · Cited by 1,230
Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol
Newkome, G. R., Yao, Z., Baker, G. R., & Gupta, V. K. (1985) · The Journal of Organic Chemistry · doi:10.1021/jo00211a052 · Cited by 1,199
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Brizel, D. M., Albers, M. E., Fisher, S. R., Scher, R. L., Richtsmeier, W. J., Hars, V., George, S. L., Huang, A. T., & Prosnitz, L. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382503 · Cited by 1,127
Tomalia, D. A. (2005) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.01.007 · Cited by 1,115
The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy
Doane, T. L., & Burda, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15260f · Cited by 1,098
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Panyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
DUFES, C., UCHEGBU, I., & SCHATZLEIN, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.017 · Cited by 984
Design of Liposomes for Enhanced Local Release of Drugs by Hyperthermia
Yatvin, M. B., Weinstein, J. N., Dennis, W. H., & Blumenthal, R. (1978) · Science · doi:10.1126/science.364652 · Cited by 956
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.006 · Cited by 956
Milk proteins as vehicles for bioactives
Livney, Y. D. (2010) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2009.11.002 · Cited by 949
Cevc, G., & Blume, G. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90154-e · Cited by 850
Chemical Design of Nanoparticle Probes for High‐Performance Magnetic Resonance Imaging
Jun, Y., Lee, J., & Cheon, J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200701674 · Cited by 839
Progress of drug-loaded polymeric micelles into clinical studies
Cabral, H., & Kataoka, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.042 · Cited by 837
Impact of albumin on drug delivery — New applications on the horizon
Elsadek, B., & Kratz, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.069 · Cited by 832
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Sinha, R., Kim, G. J., Nie, S., & Shin, D. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0141 · Cited by 801
Fonseca, C., Simões, S., & Gaspar, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00212-2 · Cited by 755
Dendrimer toxicity: Let's meet the challenge
Jain, K., Kesharwani, P., Gupta, U., & Jain, N. K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.027 · Cited by 710
Shuai, X., Ai, H., Nasongkla, N., Kim, S., & Gao, J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.003 · Cited by 695
Souto, E. B., Wissing, S. A., Barbosa, C. M., & Müller, R. H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.02.032 · Cited by 692
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Bae, Y., & Kataoka, K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.016 · Cited by 669
Kojima, C., Kono, K., Maruyama, K., & Takagishi, T. (2000) · Bioconjugate Chemistry · doi:10.1021/bc0000583 · Cited by 663
Greco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 652
Nonionic surfactant vesicular systems for effective drug delivery—an overview
Kumar, G. P., & Rajeshwarrao, P. (2011) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2011.09.002 · Cited by 644
The Current Status of Camptothecin Analogues as Antitumor Agents
Slichenmyer, W. J., Rowinsky, E. K., Donehower, R. C., & Kaufmann, S. H. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.271 · Cited by 618
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
Decuzzi, P., Pasqualini, R., Arap, W., & Ferrari, M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9697-x · Cited by 616
Folate-targeted therapeutic and imaging agents for cancer
Low, P. S., & Kularatne, S. A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.022 · Cited by 585
DEMANUELE, A., & ATTWOOD, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.012 · Cited by 571
Needham, D., & Dewhirst, M. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00233-2 · Cited by 570
Dendrimers as versatile platform in drug delivery applications
Svenson, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.023 · Cited by 570
Preparation and characterization of liposomes as therapeutic delivery systems: a review
Vemuri, S., & Rhodes, C. T. (1995) · Pharmaceutica Acta Helvetiae · doi:10.1016/0031-6865(95)00010-7 · Cited by 564
Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates
Trail, P. A., Willner, D., Lasch, S. J., Henderson, A. J., Hofstead, S., Casazza, A. M., Firestone, R. A., Hellström, I., & Hellström, K. E. (1993) · Science · doi:10.1126/science.8327892 · Cited by 556
Stimuli-Responsive Supramolecular Assemblies of Linear-Dendritic Copolymers
Gillies, E. R., Jonsson, T. B., & Fréchet, J. M. J. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0463738 · Cited by 549
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
Torchilin, V. P., Lukyanov, A. N., Gao, Z., & Papahadjopoulos-Sternberg, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931428100 · Cited by 538
Niosomes from 80s to present: The state of the art
Marianecci, C., Di Marzio, L., Rinaldi, F., Celia, C., Paolino, D., Alhaique, F., Esposito, S., & Carafa, M. (2014) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.11.018 · Cited by 536
Yoo, J.-W., Chambers, E., & Mitragotri, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920496 · Cited by 521
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels, T. R., Delgado, T., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 518
Cheng, Y., Zhao, L., Li, Y., & Xu, T. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00097c · Cited by 515
Cevc, G. (1996) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v13.i3-4.30 · Cited by 506
Kong, G., Anyarambhatla, G., Petros, W. P., Braun, R. D., Colvin, O. M., Needham, D., & Dewhirst, M. W. (2000) · PubMed · Cited by 505
Oral delivery of anticancer drugs: Challenges and opportunities
Thanki, K., Gangwal, R. P., Sangamwar, A. T., & Jain, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.020 · Cited by 499
Kievit, F. M., & Zhang, M. (2011) · Advanced Materials · doi:10.1002/adma.201102313 · Cited by 496
Cancer: Principles and Practice of Oncology
Steele, G. D. (1983) · Archives of Surgery · doi:10.1001/archsurg.1983.01390060092027 · Cited by 485
Tyrrell, Z. L., Shen, Y., & Radosz, M. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.06.003 · Cited by 481
Theranostic Nanomedicine for Cancer
Sumer, B., & Gao, J. (2008) · Nanomedicine · doi:10.2217/17435889.3.2.137 · Cited by 478
Jores, K., Mehnert, W., Drechsler, M., Bunjes, H., Johann, C., & Mäder, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.11.012 · Cited by 472
PEG-based micelles as carriers of contrast agents for different imaging modalities
Torchilin, V. P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00019-4 · Cited by 470
Liposome-based drug delivery in breast cancer treatment
Park, J. W. (2002) · Breast Cancer Research · doi:10.1186/bcr432 · Cited by 469
Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry
Uchegbu, I. F., & Florence, A. T. (1995) · Advances in Colloid and Interface Science · doi:10.1016/0001-8686(95)00242-i · Cited by 467
Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
Gabizon, A. A. (2001) · Cancer Investigation · doi:10.1081/cnv-100103136 · Cited by 458
Drug-loaded nanoparticles : preparation methods and drug targeting issues
Allémann, É., Gurny, R., & Doelker, É. (1993) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 454
Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration
Cheng, Y., Xu, Z., Ma, M., & Xu, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21079 · Cited by 452
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Physiology and Physiopathology of the Reticuloendothelial System
Saba, T. M. (1970) · Archives of Internal Medicine · doi:10.1001/archinte.126.6.1031 · Cited by 434
Dendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417
Taratula, O., Kuzmov, A., Shah, M., Garbuzenko, O. B., & Minko, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.018 · Cited by 416
Casein micelle structure: Models and muddles
Horne, D. S. (2006) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2005.11.004 · Cited by 403
Dendrimer-platinate: a novel approach to cancer chemotherapy
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199909000-00010 · Cited by 402
Lee, E. S., Gao, Z., Kim, D., Park, K., Kwon, I. C., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.024 · Cited by 400
Liposomes: an overview of manufacturing techniques.
Mozafari, M. R. (2005) · PubMed · Cited by 399
Nanotheranostics and image-guided drug delivery: current concepts and future directions
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100228v · Cited by 397
Nanocarriers for delivery of platinum anticancer drugs
Oberoi, H. S., Nukolova, N. V., Kabanov, A. V., & Bronich, T. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.014 · Cited by 396
Tiruppathi, C., Song, W., Bergenfeldt, M., Sass, P., & Malik, A. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25968 · Cited by 391
Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target
Beningo, K. A., & Wang, Y.-L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.4.849 · Cited by 389
Niosomes: Novel sustained release nonionic stable vesicular systems — An overview
Mahale, N. B., Thakkar, P. D., Mali, R. G., Walunj, D. R., & Chaudhari, S. R. (2012) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2012.08.002 · Cited by 383
Dendrimers: Novel Polymeric Nanoarchitectures for Solubility Enhancement
Gupta, U., Agashe, H. B., Asthana, A., & Jain, N. K. (2006) · Biomacromolecules · doi:10.1021/bm050802s · Cited by 375
Red blood cell-mimicking synthetic biomaterial particles
Doshi, N., Zahr, A. S., Bhaskar, S., Lahann, J., & Mitragotri, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907127106 · Cited by 374
Vesicles as a tool for transdermal and dermal delivery
Honeywell-Nguyen, P. L., & Bouwstra, J. A. (2005) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2005.05.003 · Cited by 365
Wu, N. Z., Da, D., Rudoll, T. L., Needham, D., Whorton, A. R., & Dewhirst, M. W. (1993) · PubMed · Cited by 364
Roser, M., Fischer, D., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00038-1 · Cited by 357
Gradishar, W. J., Krasnojon, D., Cheporov, S., Makhson, A. N., Manikhas, G. M., Clawson, A., & Bhar, P. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5397 · Cited by 341
Cevc, G., Schätzlein, A., & Richardsen, H. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00401-7 · Cited by 340
Shenoy, D. B., & Amiji, M. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.010 · Cited by 331
Teeranachaideekul, V., Souto, E. B., Junyaprasert, V. B., & Müller, R. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.015 · Cited by 323
Size and Dynamics of Caveolae Studied Using Nanoparticles in Living Endothelial Cells
Wang, Z., Tiruppathi, C., Minshall, R. D., & Malik, A. B. (2009) · ACS Nano · doi:10.1021/nn9012274 · Cited by 319
Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery
Jiao, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.002 · Cited by 314
Muggia, F. M., Creaven, P. J., Hansen, H. H., Cohen, M. H., & Selawry, O. S. (1972) · PubMed · Cited by 312
Seymour (2009) · International Journal of Oncology · doi:10.3892/ijo_00000293 · Cited by 304
Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin
Tuan Giam Chuang, V., Kragh-Hansen, U., & Otagiri, M. (2002) · Pharmaceutical Research · doi:10.1023/a:1015396825274 · Cited by 295
Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development
Drummond, D. C., Noble, C. O., Hayes, M. E., Park, J. W., & Kirpotin, D. B. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21358 · Cited by 289
Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration
El Maghraby, G. M. M., Williams, A. C., & Barry, B. W. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00441-x · Cited by 286
Deformable liposomes for dermal administration of methotrexate
Trotta, M., Peira, E., Carlotti, M. E., & Gallarate, M. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.10.006 · Cited by 285
Liposomen: Möglichkeiten der Medikamentenfreisetzung
Allen, T. M. (1997) · Drugs · doi:10.2165/00003495-199700544-00004 · Cited by 279
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Dreis, S., Rothweiler, F., Michaelis, M., Cinatl, J., Kreuter, J., & Langer, K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.036 · Cited by 275
Yoo, J.-W., Doshi, N., & Mitragotri, S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.004 · Cited by 272
Randomized Phase II Study of BR96-Doxorubicin Conjugate in Patients With Metastatic Breast Cancer
Tolcher, A. W., Sugarman, S., Gelmon, K. A., Cohen, R., Saleh, M., Isaacs, C., Young, L., Healey, D., Onetto, N., & Slichenmyer, W. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.478 · Cited by 271
Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networks
Gaber, M. H., Wu, N. Z., Hong, K., Huang, S. K., Dewhirst, M. W., & Papahadjopoulos, D. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00389-6 · Cited by 271
Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer
Yang, X.-Y., Li, Y.-X., Li, M., Zhang, L., Feng, L.-X., & Zhang, N. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.07.002 · Cited by 262
Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet.
Gabizón, A. (2001) · PubMed · Cited by 259
Paclitaxel-Loaded Gelatin Nanoparticles for Intravesical Bladder Cancer Therapy
Lu, Z., Yeh, T.-K., Tsai, M., Au, J. L.-S., & Wientjes, M. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1443 · Cited by 256
Matsumura, Y., Gotoh, M., Muro, K., Yamada, Y., Shirao, K., Shimada, Y., Okuwa, M., Matsumoto, S., Miyata, Y., Ohkura, H., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh092 · Cited by 253
Minko, T., Kopečková, P., Pozharov, V., & Kopeček, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00009-1 · Cited by 243
Drug targeting and tumor heterogeneity
Bae, Y. H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.074 · Cited by 233
Kim, S. Y., & Lee, Y. M. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00292-1 · Cited by 227
Hong, R. L., Huang, C. J., Tseng, Y., Pang, V. F., Chen, S.-T., Liu, J. J., & Chang, F. (1999) · PubMed · Cited by 227
Ye, F., Barrefelt, Å., Asem, H., Abedi-Valugerdi, M., El-Serafi, I., Saghafian, M., Abu-Salah, K., Alrokayan, S., Muhammed, M., & Hassan, M. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.041 · Cited by 222
Drug targeting to the colon with lectins and neoglycoconjugates
Minko, T. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.017 · Cited by 222
Gamelin, E. C., Danquechin-Dorval, E. M., Dumesnil, Y. F., Maillart, P. J., Goudier, M. J., Burtin, P. C., Delva, R. G., Lortholary, A. H., Gesta, P. H., & Larra, F. G. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960201)77:3<441::aid-cncr4>3.0.co;2-n · Cited by 218
Schnitzer, J. E. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.262.1.h246 · Cited by 217
Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium
Torchilin, V. P., Klibanov, A. L., Huang, L., O'Donnell, S., Nossiff, N. D., & Khaw, B. A. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.9.1612296 · Cited by 216
Percutaneous Penetration Enhancers: Overview
Zhai, H., Maibach, H., & Thong, H.-Y. (2007) · Dermatotoxicology, Seventh Edition · doi:10.1201/9781420009774.ch5 · Cited by 216
Possibility of active targeting to tumor tissues with liposomes
Maruyama, K., Ishida, O., Takizawa, T., & Moribe, K. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00042-3 · Cited by 211
Commercial challenges of protein drug delivery
Brown, L. R. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.29 · Cited by 208
Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro
El Maghraby, G. M. M., Williams, A. C., & Barry, B. W. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776450 · Cited by 204
Submicron Emulsions in Drug Targeting and Delivery
(2019) · CRC Press eBooks · doi:10.1201/9780367810528 · Cited by 199
5-fluorouracil induced cardiotoxicity: Review of the literature
Sorrentino, M. F., Kim, J., Foderaro, A. E., & Truesdell, A. G. (2012) · Cardiology Journal · doi:10.5603/cj.2012.0084 · Cited by 196
Pradhan, M., Singh, D., & Singh, M. R. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.020 · Cited by 190
Ke, X.-Y., Lin Ng, V. W., Gao, S.-J., Tong, Y. W., Hedrick, J. L., & Yang, Y. Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.049 · Cited by 185
Ahn, H. K., Jung, M., Sym, S. J., Shin, D. B., Kang, S. M., Kyung, S. Y., Park, J.-W., Jeong, S. H., & Cho, E. K. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2498-5 · Cited by 183
Chen, X., Gambhir, S. S., & Cheon, J. (2011) · Accounts of Chemical Research · doi:10.1021/ar200231d · Cited by 183
Tian, G., Zheng, X., Zhang, X., Yin, W., Yu, J., Wang, D., Zhang, Z., Yang, X., Gu, Z., & Zhao, Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.11.022 · Cited by 182
Lv, S., Tang, Z., Zhang, D., Song, W., Li, M., Lin, J., Liu, H., & Chen, X. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.009 · Cited by 181
Human serum albumin–polyethylenimine nanoparticles for gene delivery
Rhaese, S., von Briesen, H., Rübsamen-Waigmann, H., Kreuter, J., & Langer, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00302-x · Cited by 180
Lipid-Core Micelles for Targeted Drug Delivery
Torchilin, V. (2005) · Current Drug Delivery · doi:10.2174/156720105774370221 · Cited by 179
Modolell, M., Andreesen, R., Pahlke, W., Brugger, U., & MUNDER, P. G. (1979) · PubMed · Cited by 178
Solid lipid nanoparticles (SLN) for controlled drug delivery
Müller, R. H., Freitas, C., zur Mühlen, A., & Mehnert, W. (1996) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)86243-4 · Cited by 174
Liposome imaging agents in personalized medicine
Petersen, A. L., Hansen, A. E., Gabizon, A., & Andresen, T. L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.003 · Cited by 164
Nanoparticle-Based Diagnosis and Therapy
Groneberg, D. A., Giersig, M., Welte, T., & Pison, U. (2006) · Current Drug Targets · doi:10.2174/138945006777435245 · Cited by 158
Ikezoe, T., Yang, Y., Bandobashi, K., Saito, T., Takemoto, S., Machida, H., Togitani, K., Koeffler, H. P., & Taguchi, H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0277 · Cited by 154
Current perspectives on camptothecins in cancer treatment
Dancey, J. E., & Eisenhauer, E. A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.362 · Cited by 150
Edwards, K. A., & Baeumner, A. J. (2005) · Talanta · doi:10.1016/j.talanta.2005.08.044 · Cited by 147
Redox-responsive polyanhydride micelles for cancer therapy
Wang, J., Yang, G., Guo, X., Tang, Z., Zhong, Z. A., & Zhou, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.025 · Cited by 140
Shapira, A., Davidson, I., Avni, N., Assaraf, Y. G., & Livney, Y. D. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.022 · Cited by 135
Transvascular drug delivery in solid tumors
Fan, Y. (1998) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(98)80042-8 · Cited by 132
Rowinsky, E. K., Rizzo, J. D., Ochoa, L., Takimoto, C. H. M., Forouzesh, B., Schwartz, G. H., Hammond, L. A., Patnaik, A., Kwiatek, J., Goetz, A. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.143 · Cited by 132
Yoo, J., Doshi, N., & Mitragotri, S. (2009) · Macromolecular Rapid Communications · doi:10.1002/marc.200900592 · Cited by 130
Paolino, D., Celia, C., Trapasso, E., Cilurzo, F., & Fresta, M. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.02.008 · Cited by 130
Wang, P., Zhang, L., Peng, H., Li, Y., Xiong, J. P., & Xu, Z. (2013) · Materials Science and Engineering C · doi:10.1016/j.msec.2013.07.047 · Cited by 126
Ye, H., Li, J., Hu, R., Yi, Z., Li, J., Wu, Y., Xi, X., & Wu, Z. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.08.016 · Cited by 125
Bissett, D., Cassidy, J., Bono, J. S. D., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601922 · Cited by 125
Multifunctionality of lipid-core micelles for drug delivery and tumour targeting
Sawant, R. R., & Torchilin, V. P. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.516276 · Cited by 123
Koshkaryev, A., Sawant, R. R., Deshpande, M., & Torchilin, V. P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.009 · Cited by 122
Abouzeid, A. H., Patel, N. R., & Torchilin, V. P. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.01.009 · Cited by 118
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin™ for active targeting
Bossy-Nobs, L., Buchegger, F., Gurny, R., & Allémann, É. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.04.006 · Cited by 117
Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
O’Shaughnessy, J. (2003) · Clinical Breast Cancer · doi:10.3816/cbc.2003.n.037 · Cited by 117
Zuidam, N. J., Gouw, H. K. M. E., Barenholz, Y., et al. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00180-5 · Cited by 115
Nanda, R., Sasmal, A., & Nayak, P. L. (2010) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2010.09.009 · Cited by 114
Investigation on the viscoelastic properties of lipid based colloidal drug carriers
Lippacher, A., Müller, R. H., & Mäder, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00428-7 · Cited by 109
Doxorubicin loaded magneto-niosomes for targeted drug delivery
Tavano, L., Vivacqua, M., Carito, V., Muzzalupo, R., Caroleo, M. C., & Nicoletta, F. P. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.09.019 · Cited by 107
Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes
Zhu, L., Huo, Z., Wang, L., Tong, X., Xiao, Y. Z., & Ni, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.003 · Cited by 102
Liposomes produced in a pilot scale: production, purification and efficiency aspects
Wagner, A., Vorauer‐Uhl, K., & Katinger, H. W. D. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00062-0 · Cited by 101
Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis
Ruiter, G. A., Verheij, M., Zerp, S. F., & BLITTERSWIJK, W. J. V. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01476-0 · Cited by 100
Yurkovetskiy, A., & Fram, R. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.01.007 · Cited by 100
Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin
Sadekar, S., Thiagarajan, G., Bartlett, K., Hubbard, D., Ray, A., McGill, L. D., & Ghandehari, H. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.07.071 · Cited by 100
Studies on the oridonin-loaded poly(d,l-lactic acid) nanoparticles in vitro and in vivo
Xing, J., Zhang, D., & Tan, T. (2007) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2006.07.001 · Cited by 99
McGuire, W. L. (1981) · Springer eBooks · doi:10.1007/978-1-4615-6571-0 · Cited by 95
Liposomes for scintigraphic detection of infection and inflammation
Laverman, P. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00095-7 · Cited by 93
Torchilin, V. P., Narula, J., Halpern, E. F., & Khaw, B. (1996) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00248-0 · Cited by 91
Salzano, G., Riehle, R. D., Navarro, G., Perche, F., Rosa, G. D., & Torchilin, V. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.037 · Cited by 91
Immunoliposomes and PEGylated Immunoliposomes: Possible Use for Targeted Delivery of Imaging Agents
Torchilin, V. P. (1994) · ImmunoMethods · doi:10.1006/immu.1994.1027 · Cited by 89
Soepenberg, O., Dumez, H., Verweij, J., de Jong, F. A., de Jonge, M. J. A., Thomas, J., Eskens, F. A. L. M., van Schaik, R. H. N., Selleslach, J., ter Steeg, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1758 · Cited by 88
Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin
Hiruta, Y., Hattori, Y., Kawano, K., Obata, Y., & Maitani, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.016 · Cited by 87
Safety and Efficacy of nab -Paclitaxel in the Treatment of Patients with Breast Cancer
Vishnu, P., & Roy, V. (2011) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s5857 · Cited by 83
Construction of hyaluronic acid noisome as functional transdermal nanocarrier for tumor therapy
Kong, M., Park, H., Feng, C., Hou, L., Cheng, X., & Chen, X. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.01.091 · Cited by 81
Design, Synthesis and Potent Pharmaceutical Applications of Glycodendrimers:A Mini Review
Li, Y., Cheng, Y., & Xu, T. (2007) · Current Drug Discovery Technologies · doi:10.2174/157016307783220503 · Cited by 79
Is transdermal drug delivery research still important today?
Barry, B. W. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01938-9 · Cited by 78
What nanomedicine in the clinic right now really forms nanoparticles?
Svenson, S. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1257 · Cited by 77
Etrych, T., Šubr, V., Laga, R., Říhová, B., & Ulbrich, K. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.02.016 · Cited by 77
IHOVA, B. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00235-9 · Cited by 77
Physicochemical aspects behind the size of biodegradable polymeric nanoparticles: A step forward
de Oliveira, A. M., Jäger, E., Jäger, A., Štěpánek, P., & Giacomelli, F. C. (2013) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2013.08.056 · Cited by 76
Phase I and Pharmacokinetic Study of DE-310 in Patients with Advanced Solid Tumors
Soepenberg, O., de Jonge, M. J. A., Sparreboom, A., de Bruin, P. C., Eskens, F. A. L. M., de Heus, G., Wanders, J., Cheverton, P., Ducharme, M. P., & Verweij, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.703.11.2 · Cited by 75
Sjögren, H. O., Isaksson, M., Willner, D., Hellström, I., Hellström, K. E., & Trail, P. A. (1997) · PubMed · Cited by 75
Hamaguchi, T., Matsumura, Y., Nakanishi, Y., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Niki, H., Hosokawa, S., Tagawa, T., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02495.x · Cited by 74
Cited by
Martins, P., Jesus, J., Santos, S., Raposo, L., Roma-Rodrigues, C., Baptista, P., & Fernandes, A. (2015) · Molecules · doi:10.3390/molecules200916852 · Cited by 716
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics
Vangijzegem, T., Stanicki, D., & Laurent, S. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1554647 · Cited by 548
Liposome-based drug co-delivery systems in cancer cells
Zununi Vahed, S., Salehi, R., Davaran, S., & Sharifi, S. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.11.073 · Cited by 307
Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier
Gharbavi, M., Amani, J., Kheiri-Manjili, H., Danafar, H., & Sharafi, A. (2018) · Advances in Pharmacological Sciences · doi:10.1155/2018/6847971 · Cited by 287
Metadata
- Authors
- Estanqueiro, M., Amaral, M. H., Conceição, J., & Sousa Lobo, J. M.
- Venue
- Colloids and Surfaces B: Biointerfaces
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 126
- Pages
- 631-648
- ISSN
- 0927-7765 (ISSN-L)
- OpenAlex
- W2088333494
- Cited by
- 298
- References
- 220
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.